Embark on a new era of drug discovery as OTAVA’s CHEMRIYA™ Virtual Chemical Space integrates with CHEESE Search, the advanced AI-powered platform by Deep MedChem.
Unparalleled Chemical Diversity:
Access a subset of CHEMRIYA™, a next-generation virtual chemical space tailored for hit expansion, hit-to-lead, and lead optimization.
|
|
Read more...
|
|
|
 Our Halogen-Enriched Fragment Library comprises 708 brominated fragments that can explore binding sites for favorable halogen bond interactions to identify unique binding modes that are complementary to those obtained from classical fragment-based screening.
|
|
Read more...
|
|
Phenotypic drug discovery is successful strategy that allows to identify substances (small molecules, peptides etc.) which alter the phenotype of cells, tissues or whole organisms in a desired manner.
|
|
Read more...
|
|
|
The Targeted AHR Modulator Library is a curated chemical screening set designed to accelerate the discovery of novel small-molecule modulators of the aryl hydrocarbon receptor (AHR) — a ligand-dependent transcription factor with key roles in immunity, cancer, inflammation, and xenobiotic metabolism.
This unique compound library supports early-stage discovery, target validation, and therapeutic innovation by providing access to structurally diverse and computationally prioritized molecules tailored for AHR-centric research and drug development programs.
|
|
Read more...
|
|
 Fragment-based lead design (FBLD) could be used to identify new metal-binding groups for metalloenzyme inhibitors. Several small-molecule chelators have been shown to effectively inhibit metalloproteins, therefore the design,
|
|
Read more...
|
|
|
|
|
|
|
Page 2 of 15 |
HOME
Overview
